Status:
UNKNOWN
Impact of Congenital Heart Disease on Neurodevelopmental Outcome
Lead Sponsor:
University of Aarhus
Collaborating Sponsors:
Aarhus University Hospital
Conditions:
Heart Defects, Congenital
Eligibility:
All Genders
18-42 years
Brief Summary
The project aims toward clarifying the underlying mechanism and the long-term impact of congenital heart disease on neurodevelopment.
Detailed Description
The project provides detailed information on the impact of congenital heart disease on neurodevelopmental outcome in adulthood. The study investigates if brain maturation and development, and the neur...
Eligibility Criteria
Inclusion
- ICD codes DX Q21.0 (VSD) or DX Q21.1 (ASD), surgically repaired VSD or open ASD
Exclusion
- lack of medical record, suffering from coronary artery disease or other congenital cardiac abnormalities, diagnosed syndromes, spontaneous closure of the atrial septum defect before inclusion-date, magnetic implants or non-MRI compatible foreign objects, pregnancy, lack of Danish language skills or suffering from severe lung disease
Key Trial Info
Start Date :
July 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2023
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03871881
Start Date
July 1 2017
End Date
August 1 2023
Last Update
May 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarhus University Hospital
Aarhus N, Denmark, 8200